CDC

Dear Research Advocate, On the Hill: Will progress be a priority? The moment you take today to advocate (that’s presumptuous of me, but I know the readers of this weekly letter are action-oriented) is timely: the House has established a preliminary topline appropriations number of $1.5 trillion for both defense and non-defense discretionary spending. This placeholder number, which tracks closely to the President’s topline, enables the House to begin the FY22 appropriations process in earnest — allocating funding to each Appropriations Subcommittee and crafting various funding bills. While the House topline may change a bit later this summer and the Senate has not yet floated a topline, the...
Dear Research Advocate, Never Again: One year ago today, the WHO officially declared COVID-19 a pandemic. Within days, statewide stay-at-home orders began across the U.S., and the road before us became frighteningly uncertain. Across the country, COVID-19 has taken almost 530,000 lives; globally, more than 2.6 million have died. Over the course of a year filled with determination, turmoil, and tragedy, the significance of science and technology became crystal clear. Because of decades of basic research, rapid response science & technology (S&T), and heroic public health efforts by individuals laser-focused on saving lives, we have three safe and effective vaccines, and, as new CDC...
Dear Research Advocate, Women in Science and Technology : March is Women’s History Month. The impact of COVID-19 on the careers of women in STEMM is the focus of a report to be released by the National Academies of Science, Engineering, and Medicine (NASEM) on March 9, 2021. How did the COVID-19 pandemic disrupt the careers of women in academic STEMM during 2020 and how might these disruptions—both positive and negative—shape future progress for women in academic STEMM? The public is invited to a discussion with NASEM committee members Eve J. Higginbotham, University of Pennsylvania; Reshma Jagsi, University of Michigan; and Erick C. Jones, University of Texas at Arlington. Register here ...
Dear Research Advocate, Perseverance and resilience anchor us as we navigate this pandemic. The recent landing of the Perseverance rover on Mars exemplifies the tenacity and commitment underlying breakthrough discoveries in science and technology. COVID-19 Therapeutics: Thanks to the perseverance of extraordinary academic and private sector researchers around the world, we now have an array of therapeutics available for a disease that a year ago was just entering the public consciousness. Earlier today, we hosted a virtual discussion focused on the what, when, and how behind COVID-19 interventions. If you were unable to join us today, I promise you will find the conversation informative,...
Dear Research Advocate, On Capitol Hill: Regrettably, there are no dollars to fill COVID-19 engendered research gaps — meaning all the many research programs put on hold or even shelved as the pandemic consumes attention — in the $1.9T relief package the House will vote on next week. That’s why we must all advocate for inclusion in the next supplemental, which is in the works. So much is at stake — answers for patients and the ability of researchers to generate those answers. The American taxpayer has invested a great deal in research and researchers; it is penny wise and pound foolish to leave so many of them high and dry at this point. Your Members of Congress can urge Congressional...
Dear Research Advocate, Fourth of July, typically a day to unwind and celebrate, comes to us this year at a fraught time in our fight against a deadly pandemic. Evidence-based public health practices to mitigate the virus’s spread have been too often politicized and unheeded, leading to adherence gaps by some that place many others at risk. Cautious optimism from public health experts that we were on a path to containing the virus is being overtaken by alarm. Public health officials in communities across the country are being physically threatened while laboring under poorly-resourced conditions. An important time to hear from Dr. Tom Frieden, former CDC Director and current President and...
Dear Research Advocate, This past Monday, CDC Director Dr. Robert Redfield was our guest for the first of two alliance member calls this week, stressing the roles we all have to play: “I think this is an all-of-the nation response, not just an all-government response…. There’s no doubt we're going to learn a lot of lessons. But, I am 100 percent confident when we get to the other side, we're going to be so much stronger.” We are grateful to Director Redfield for spending time with us. Read more here . Innovation is key : Dr. Redfield repeatedly called for innovation: “I look forward to the innovation that we’re going to see from many of [Research!America’s] members to improve the tools we...
Research!America hosted an alliance member call for members and partners on April 13, 2020 with Dr. Robert Redfield, Director, Centers for Disease Control and Prevention. Dr. Redfield opened with an overview of the COVID-19 pandemic and the CDC’s response. He stressed that COVID-19 is the greatest public health challenge the United States has faced in over a century and highlighted the CDC’s deployment of personnel, development and expansion of serology testing, and distribution of funding to state, local, and tribal public health departments. He also emphasized that our nation should use this time to expand the existing public health infrastructure in order to be better prepared for future...
Dear Research Advocate, Because Research!America’s membership spans the ecosystem of stakeholders in research, we are fortunate to have access to a broad and comprehensive range of information you might find helpful. Visit and share our COVID-19 webpage. www.ResearchAmerica.org/COVID19 . A CDC report just out indicates that younger Americans have been hospitalized with COVID-19 at a higher rate than anticipated. As we look ahead to the use of vaccines against this and other threats, we have new (in the field just last evening) survey data showing that almost two-thirds of Americans ages 18-29 may not fully understand the role of vaccines. Better news is that this demographic is increasingly...
Dear Research Advocate, In their different ways, Super Tuesday and COVID-19 both speak to public sentiment. What are Americans’ expectations for those who represent them in Washington — and candidates who want to represent them in Washington — when it comes to promoting and protecting their best interests? A new Research!America-commissioned survey (in the field just days before COVID-19 captured worldwide public attention) found that Americans want their policymakers to consult with public health professionals and scientists; are deeply concerned about a diversity of public health issues affecting their families, their communities, and our nation as a whole; and believe there should be...

Pages

Sidebar Quote

The capabilities are enormous, a little bit of research can pay off quite a bit in the long run.
Paul D’ Addario, retinitis pigmentosa patient